Award to be presented at Committee of 100’s 2023 Annual Conference & Gala “Seeking Common Ground,” taking place in San Jose, California from May 5-6
New York, NY (March 23, 2023) – Committee of 100, a non-profit organization of prominent Chinese Americans, today announced that Dr. Jean Cui, President and CEO of BlossomHill Therapeutics and Dr. Peter Li, Chairman of BlossomHill Therapeutics will receive the Committee of 100 Circle of Excellence Award for Humanity in Science & Technology. The award is given to the group or individual who pursues clinical science advancements for humankind on an international scale, utilizing science, technology and research for such advancements.
Drs. Cui and Li co-founded Turning Point Therapeutics, Inc., a NASDAQ listed biotech company before it was acquired by Bristol Meyers Squibb for $4.1 Billion in June 2022. Dr. Cui was the Chief Scientific Officer at Turning Point from its founding in October 2013 to January 2020 and created 4 clinical compounds for addressing cancer resistance, with the leading compound, Repotrectinib, achieving 3 FDA Breakthrough Therapy designations, 3 FDA Fast-Track designations, and 1 FDA Orphan Drug designation to date. Dr. Cui is the lead inventor of Pfizer’s precision oncology medicine, Crizotinib (XalkoriTM). Crizotinib gained fast-track approval from the FDA in 2011 for ALK-positive late-stage non-small cell lung cancer (NSCLC). After Crizotinib, Dr. Cui designed the next-generation ALK medicine Lorlatinib (LORBRENATM) for fighting treatment resistance from the 1st generation ALK medicine. Dr. Li served as Chairman and CEO of Turning Point from its founding to September 2018 and successfully raised a total of $147 million in venture financing from leading biotech investors.
This year’s Conference & Gala theme is “Seeking Common Ground in Turbulent Times.” For three decades, Committee of 100’s Conference & Gala has convened distinguished academics, policymakers, businesses, and next-generation leaders from across the U.S. for a series of discussions, debates, keynotes, and networking sessions. Participants share a common goal of advocating for and promoting the full participation of all Chinese Americans in American society.
The must-attend event will take place at the Signia by Hilton San Jose May 5-6. Content will focus on diplomacy, economic interdependence, education, technology, anti-Asian hate, and more.
In the coming weeks, panel discussions, breakouts, additional award winners, and keynote speakers will be announced. Registration for the Conference & Gala is now available here.
To make inquiries regarding sponsorship opportunities, please contact sponsorship@committee100.org.
Committee of 100 would like to thank its current sponsors in the support of the Conference & Gala: Hsieh Family Foundation (Jade), Kenson Ventures (Diamond), Eric S. Yuan (Platinum), Buck J. Gee, Jerry Yang (Silver), Wells Fargo (Bronze), Anla Cheng, Carter Tseng, and State Street (Pearl).
Accredited media interested in attending can reach out to media@committee100.org.
About Committee of 100
Committee of 100 is a non-profit U.S. leadership organization of prominent Chinese Americans in business, government, academia, healthcare, and the arts focused on public policy engagement, civic engagement, and philanthropy. For more than 30 years, Committee of 100 has served as a preeminent organization committed to the dual missions of promoting the full participation of Chinese Americans in all aspects of American life and constructive relations between the United States and Greater China. Visit https://www.committee100.org/ or follow Committee of 100 on LinkedIn, Twitter, and Facebook for more information.
The official hashtag for the 2023 Committee of 100 Conference & Gala is #SeekingCommonGround.
# # #
